Document is current
Any future updates will be listed below
-
Authors
Stetefeld, Henning https://orcid.org/0000-0002-8853-2145
Schroeter, Michael
- License Information
-
More Information
Article History
Received: 1 April 2019
Accepted: 16 April 2019
First Online: 29 July 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: H. Stetefeld declares that he has no competing interests.M. Schroeter has received speaking fees from Alexion, Biogen, Genzyme/Sanofi, Grifols, Miltenyi Biotec, Novartis.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
